• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗前中性粒细胞与淋巴细胞比值可预测接受雷珠单抗治疗的糖尿病性黄斑水肿患者的预后。

Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with diabetic macular edema treated with ranibizumab.

机构信息

Department of Ophthalmology, the First Affiliated Hospital of Nanchang University, No. 17, Nanchang, 330006, China.

Department of Ophthalmology, Xinjiang People's Hospital, Urumqi, China.

出版信息

BMC Ophthalmol. 2019 Aug 27;19(1):194. doi: 10.1186/s12886-019-1200-4.

DOI:10.1186/s12886-019-1200-4
PMID:31455273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6712590/
Abstract

BACKGROUND

To investigate the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in patients with diabetic macular edema (DME) treated monthly with ranibizumab.

METHODS

We retrospectively analyzed the medical records of all patients who received intravitreal ranibizumab (IVR) treatment for DME at the First Affiliated Hospital of Nanchang University between December 2015 and December 2017. Clinicopathological parameters, including NLR, were evaluated to identify predictors of better outcomes of IVR monotherapy.

RESULTS

Ninety-one treatment-naïve eyes treated with IVR for DME were retrospectively analyzed in this study. Baseline best-corrected visual acuity (BCVA), neutrophils, NLR, monocyte-to-lymphocyte ratio, and platelet-to-lymphocyte ratio were negatively correlated with the changes in BCVA at 24 weeks compared with the baseline, while baseline central retinal thickness and lymphocytes were positively correlated with the changes in BCVA at 24 weeks compared with the baseline. Multiple linear regression analysis revealed that NLR was independently associated with the mean change of BCVA between baseline and week 24. In addition, patients with NLR < 2.27 showed a better improvement in letter score than those with NLR > 2.27.

CONCLUSION

Pretreatment NLR is independently associated with the BCVA in DME patients treated with IVR, and higher pretreatment NLR may contribute to inferior BCVA outcomes.

摘要

背景

研究每月接受雷珠单抗治疗的糖尿病黄斑水肿(DME)患者中性粒细胞与淋巴细胞比值(NLR)的预后价值。

方法

我们回顾性分析了 2015 年 12 月至 2017 年 12 月期间在南昌大学第一附属医院接受玻璃体内雷珠单抗(IVR)治疗的所有 DME 患者的病历。评估包括 NLR 在内的临床病理参数,以确定 IVR 单一疗法更好结果的预测因素。

结果

本研究回顾性分析了 91 例接受 IVR 治疗的 DME 治疗初治眼。与基线相比,基线最佳矫正视力(BCVA)、中性粒细胞、NLR、单核细胞与淋巴细胞比值和血小板与淋巴细胞比值与 24 周时 BCVA 的变化呈负相关,而基线中央视网膜厚度和淋巴细胞与 24 周时 BCVA 的变化呈正相关。多元线性回归分析显示,NLR 与基线至 24 周时 BCVA 的平均变化独立相关。此外,NLR<2.27 的患者比 NLR>2.27 的患者字母评分改善更好。

结论

治疗前 NLR 与 IVR 治疗的 DME 患者的 BCVA 独立相关,较高的治疗前 NLR 可能导致较差的 BCVA 结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5182/6712590/5a9c5e29caf4/12886_2019_1200_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5182/6712590/5a9c5e29caf4/12886_2019_1200_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5182/6712590/5a9c5e29caf4/12886_2019_1200_Fig1_HTML.jpg

相似文献

1
Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with diabetic macular edema treated with ranibizumab.治疗前中性粒细胞与淋巴细胞比值可预测接受雷珠单抗治疗的糖尿病性黄斑水肿患者的预后。
BMC Ophthalmol. 2019 Aug 27;19(1):194. doi: 10.1186/s12886-019-1200-4.
2
Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice.在临床实践中,抗血管内皮生长因子药物雷珠单抗单药治疗糖尿病性黄斑水肿取得更好疗效的预测因素。
Medicine (Baltimore). 2017 Apr;96(16):e6459. doi: 10.1097/MD.0000000000006459.
3
Enhanced Benefit in Diabetic Macular Edema from AKB-9778 Tie2 Activation Combined with Vascular Endothelial Growth Factor Suppression.AKB-9778 Tie2 激活联合血管内皮生长因子抑制治疗糖尿病性黄斑水肿的获益增强。
Ophthalmology. 2016 Aug;123(8):1722-1730. doi: 10.1016/j.ophtha.2016.04.025. Epub 2016 May 26.
4
Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema.玻璃体内注射雷珠单抗对糖尿病性黄斑水肿患者脉络膜结构和血流的影响。
Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):885-892. doi: 10.1007/s00417-018-3939-3. Epub 2018 Mar 1.
5
Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.玻璃体内注射雷珠单抗治疗伴有浆液性视网膜脱离的糖尿病性黄斑水肿的疗效
Korean J Ophthalmol. 2018 Aug;32(4):296-302. doi: 10.3341/kjo.2017.0117.
6
Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE.抗 VEGF 药物治疗糖尿病黄斑水肿初始疗效有限患者的视力和解剖学结局: RIDE 和 RISE 研究
Ophthalmology. 2016 Jun;123(6):1345-50. doi: 10.1016/j.ophtha.2016.02.007. Epub 2016 Mar 15.
7
A Comparison Study of Ranibizumab and Aflibercept in Patients with Naive Diabetic Macular Edema in Presence of Serous Retinal Detachment.在存在浆液性视网膜脱离的情况下,雷珠单抗和阿柏西普在初发糖尿病性黄斑水肿患者中的对比研究。
Curr Eye Res. 2019 Sep;44(9):987-993. doi: 10.1080/02713683.2019.1608260. Epub 2019 Apr 29.
8
Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial.糖尿病性黄斑水肿伴周边视网膜无灌注的靶向视网膜光凝治疗:三年随机 DAVE 试验。
Ophthalmology. 2018 May;125(5):683-690. doi: 10.1016/j.ophtha.2017.11.026. Epub 2018 Jan 11.
9
Predictors of Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Ranibizumab.接受雷珠单抗治疗的糖尿病黄斑水肿患者的功能和解剖学结局的预测因素。
Ophthalmology. 2015 Jul;122(7):1395-401. doi: 10.1016/j.ophtha.2015.02.036. Epub 2015 Apr 11.
10
EFFECT OF REIMBURSEMENT POLICY ON VISUAL OUTCOMES IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH RANIBIZUMAB.抗 VEGF 药物治疗糖尿病黄斑水肿患者的医保报销政策对视力结局的影响
Retina. 2020 Nov;40(11):2191-2197. doi: 10.1097/IAE.0000000000002716.

引用本文的文献

1
Predictive Role of Complete Blood Count-Derived Inflammation Indices and Optical Coherence Tomography Biomarkers for Early Response to Intravitreal Anti-VEGF in Diabetic Macular Edema.全血细胞计数衍生的炎症指标和光学相干断层扫描生物标志物对糖尿病性黄斑水肿玻璃体内抗VEGF治疗早期反应的预测作用
Biomedicines. 2025 May 27;13(6):1308. doi: 10.3390/biomedicines13061308.
2
Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes.肠道中性粒细胞胞外诱捕网会加剧肠道屏障损伤,加重2型糖尿病患者的内毒素血症、全身炎症反应及糖尿病视网膜病变进展。
Diabetologia. 2025 Apr;68(4):866-889. doi: 10.1007/s00125-024-06349-4. Epub 2025 Jan 28.
3

本文引用的文献

1
The prognostic value of lymphocyte-to-monocyte ratio in retinopathy of prematurity.淋巴细胞与单核细胞比值在早产儿视网膜病变中的预后价值
Int J Ophthalmol. 2017 Nov 18;10(11):1716-1721. doi: 10.18240/ijo.2017.11.13. eCollection 2017.
2
Neutrophils in cancer: prognostic role and therapeutic strategies.中性粒细胞与癌症:预后作用和治疗策略。
Mol Cancer. 2017 Aug 15;16(1):137. doi: 10.1186/s12943-017-0707-7.
3
Effect of Monocyte-to-Lymphocyte Ratio on Heart Failure Characteristics and Hospitalizations in a Coronary Angiography Cohort.
The Neutrophil to Lymphocyte Ratio and Other Full Blood Count Indices in Retinal Diseases: A Systematic Review of the Literature.
视网膜疾病中的中性粒细胞与淋巴细胞比值及其他全血细胞计数指标:文献系统综述
Medicina (Kaunas). 2025 Jan 14;61(1):125. doi: 10.3390/medicina61010125.
4
The Predictors of Early Treatment Effectiveness of Intravitreal Bevacizumab Application in Patients with Diabetic Macular Edema.玻璃体内注射贝伐单抗治疗糖尿病性黄斑水肿患者早期治疗效果的预测因素
Diagnostics (Basel). 2024 May 10;14(10):992. doi: 10.3390/diagnostics14100992.
5
Association Between Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) With Diabetic Retinopathy in Type 2 Diabetic Patients.2型糖尿病患者中性粒细胞与淋巴细胞比值(NLR)及血小板与淋巴细胞比值(PLR)与糖尿病视网膜病变的关系
Cureus. 2023 Nov 9;15(11):e48581. doi: 10.7759/cureus.48581. eCollection 2023 Nov.
6
Construction and clinical validation of a nomogram-based predictive model for diabetic retinopathy in type 2 diabetes.2型糖尿病视网膜病变基于列线图预测模型的构建与临床验证
Am J Transl Res. 2023 Oct 15;15(10):6083-6094. eCollection 2023.
7
The Value of White Cell Inflammatory Biomarkers as Potential Predictors for Diabetic Retinopathy in Type 2 Diabetes Mellitus (T2DM).白细胞炎症生物标志物作为2型糖尿病(T2DM)患者糖尿病视网膜病变潜在预测指标的价值
Biomedicines. 2023 Jul 26;11(8):2106. doi: 10.3390/biomedicines11082106.
8
The role of blood neutrophil lymphocyte ratio in predicting the initial response to anti-VEGF treatment in neovascular AMD patients.中性粒细胞/淋巴细胞比值在预测新生血管性年龄相关性黄斑变性患者抗 VEGF 治疗初始反应中的作用。
Ir J Med Sci. 2024 Feb;193(1):517-521. doi: 10.1007/s11845-023-03379-6. Epub 2023 May 29.
9
Real-World Evidence in the Management of Diabetic Macular Edema with Intravitreal Anti-VEGFs in Asia: A Systematic Literature Review.亚洲玻璃体腔内注射抗血管内皮生长因子治疗糖尿病性黄斑水肿的真实世界证据:一项系统文献综述
Clin Ophthalmol. 2022 Oct 19;16:3503-3526. doi: 10.2147/OPTH.S378392. eCollection 2022.
10
Association of White Blood Cell Counts, Leukocyte Ratios, and Serum Uric Acid with Clinical Outcome of Intravitreal Bevacizumab in Diabetic Macular Edema.白细胞计数、白细胞比值和血尿酸与玻璃体内注射贝伐单抗治疗糖尿病性黄斑水肿的临床结局的关系。
Korean J Ophthalmol. 2022 Jun;36(3):244-252. doi: 10.3341/kjo.2021.0041. Epub 2022 May 6.
单核细胞与淋巴细胞比值对冠状动脉造影队列中的心衰特征及住院情况的影响
Am J Cardiol. 2017 Sep 15;120(6):911-916. doi: 10.1016/j.amjcard.2017.06.020. Epub 2017 Jun 29.
4
Ranibizumab in the Treatment of Diabetic Macular Edema: A Review of the Current Status, Unmet Needs, and Emerging Challenges.雷珠单抗治疗糖尿病性黄斑水肿:现状、未满足的需求及新出现的挑战综述
Adv Ther. 2017 Jun;34(6):1270-1282. doi: 10.1007/s12325-017-0548-1. Epub 2017 May 8.
5
Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice.在临床实践中,抗血管内皮生长因子药物雷珠单抗单药治疗糖尿病性黄斑水肿取得更好疗效的预测因素。
Medicine (Baltimore). 2017 Apr;96(16):e6459. doi: 10.1097/MD.0000000000006459.
6
High Neutrophil-to-Lymphocyte Ratio Predicts Cardiovascular Mortality in Chronic Hemodialysis Patients.高中性粒细胞与淋巴细胞比值可预测慢性血液透析患者的心血管死亡率。
Mediators Inflamm. 2017;2017:9327136. doi: 10.1155/2017/9327136. Epub 2017 Feb 21.
7
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer.治疗前中性粒细胞与淋巴细胞比值作为纳武单抗治疗晚期非小细胞肺癌患者预后的标志物。
Lung Cancer. 2017 Apr;106:1-7. doi: 10.1016/j.lungcan.2017.01.013. Epub 2017 Jan 25.
8
Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can risk stratify patients in transcatheter aortic-valve replacement (TAVR).中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)可对经导管主动脉瓣置换术(TAVR)患者进行风险分层。
Int J Cardiol. 2016 Nov 15;223:444-449. doi: 10.1016/j.ijcard.2016.08.260. Epub 2016 Aug 15.
9
The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?术前血小板与淋巴细胞比值和中性粒细胞与淋巴细胞比值:哪一个作为口腔鳞状细胞癌的预后因素更好?
Ther Adv Med Oncol. 2016 May;8(3):160-7. doi: 10.1177/1758834016638019. Epub 2016 Mar 27.
10
Neutrophil-to-Lymphocyte Ratio Predicts the Outcome of Acute Intracerebral Hemorrhage.中性粒细胞与淋巴细胞比值预测急性脑出血的转归。
Stroke. 2016 Jun;47(6):1654-7. doi: 10.1161/STROKEAHA.116.013627. Epub 2016 May 10.